PROG NUCLEIC ACID RES&MOLECULAR BIO V22

AUTHOR, UNKNOWN

In stock
Regular price 27.000 KD inc. VAT
License
Table of contents
  • Cover
  • Contentsv
  • List of Contributorsix
  • Abbreviations and Symbolsxi
  • Some Articles Planned for Future Volumesxv
  • Chapter 1. The -C-C-A End of tRNA and Its Role in Protein Biosynthesis1
  • I . Introduction2
  • II . Structure of the -N-C-C-A Terminus3
  • III. Structure of Aminoacyl-tRNA10
  • IV. Enzymic Modification of the 3' End of tRNA14
  • V. Aminoacylation of tRNA23
  • VI. Positional Specificity of Aminoacylation and Chemical ŽProofreadingŽ39
  • VII. Binding of Aminoacyl-tRNA to Ribosomes46
  • VIII. Ribosomal Peptidyltransferase Center59
  • References63
  • Chapter 2. The Mechanism of Action of Antitumor Platinum Compounds71
  • I. Introduction71
  • II. Chemical Features of Platinum Drugs75
  • III. Biological Effects of Platinum Coordination Complexes Indicative of Reactions with DNA85
  • IV. Biochemical Effects of Platinum Complexes Indicative of Reactions with DNA88
  • V. Interaction of Platinum Compounds with DNA94
  • VI. Repair of DNA Damage Induced by Platinum Complexes in Vivo110
  • VII. Concluding Remarks128
  • References129
  • Chapter 3. DNA Glycosylases, Endonucleases for Apurinic/Apyrimidinic Sites, and Base Excision-Repair135
  • I. Introduction135
  • II. Models for Excision-Repair of DNA136
  • III. DNA Glycosylases145
  • IV. Endonucleases for Apurinic/Apyrimidinic Sites (AP Endonucleases)173
  • V. Repair of Apurinic Sites in DNA by Alternative Pathways187
  • References188
  • Chapter 4. Naturally Occurring Nucleoside and Nucleotide Antibiotics193
  • Introduction193
  • I. Inhibitors of Protein Synthesis196
  • II. Inhibitors of RNA Synthesis209
  • III. Inhibitors of DNA Synthesis, DNA Viruses, and RNA Viruses239
  • IV. Inhibitors of Adenosine Deaminase and Effectors of the Immune Response245
  • V. Inhibitors of Cell- Wall Synthesis and Antifungal Agents249
  • VI. Inhibitors of Purine and Pyrimidine lnterconversions266
  • VII. Hyperesthetic and Hyperemic Agents269
  • VIII. Cyclic-AMP Phosphodiesterase Inhibitors269
  • IX. Miscellaneous Naturally Occurring Nucleosides270
  • References272
  • Chapter 5. Genetically Controlled Variation in the Shapes of Enzymes293
  • I. Introduction293
  • II. Internal Standardization294
  • III. The Interaction of Protein Size and Charge during Electrophoresis295
  • IV. Detecting "Hidden" Variation in Shape303
  • V. The Nature of Cryptic Variants305
  • VI. Major Unresolved Issues: Posttranslational Modification315
  • VII. Novel Approaches to Electrophoresis321
  • References325
  • Chapter 6. Transcription Units for mRNA Production in Eukaryotic Cells and Their DNA Viruses327
  • I. Introduction327
  • II . Techniques for Defining Transcription Units329
  • III. Definition of Transcription Units for mRNA331
  • IV. The Precursor Relationship of Large Nuclear Primary Transcripts to mRNA337
  • V. Recent Evidence on the Formation of mRNA from Primary Transcripts339
  • VI. Models for the Regulation of Eukaryotic Gene Expression344
  • VII. Conclusion349
  • References350
  • Note Added In Proof353
  • Index355
  • Contents of Previous Volumes358
Book details
  • Vendor Elsevier S & T
  • SKU 9780125400220
  • ISBN-13 9780080863108
  • Author AUTHOR, UNKNOWN
  • Category Medical
  • Subject Pharmacology

Do you have questions about this book?

Ask an expert!

PROG NUCLEIC ACID RES&MOLECULAR BIO V22